The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S1
Journal	European Journal of Endocrinology
Volume	156 Suppl 1
Publication status	Published - Apr 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

TY - JOUR

T1 - The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.

AU - Colao, A.

AU - Hofland, L. J.

PY - 2007/4

Y1 - 2007/4

UR - https://www.scopus.com/pages/publications/79959337536

UR - https://academic.oup.com/ejendo/article-abstract/156/Supplement_1/S1/6695805?redirectedFrom=fulltext&login=false#no-access-message

M3 - Article

C2 - 17413182

AN - SCOPUS:79959337536

SN - 0804-4643

VL - 156 Suppl 1

SP - S1

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

ER -